(NASDAQ:LFMD),(NASDAQ:SMLR),(NasdaqGM:QMCO), ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: LifeMD, Inc. (LFMD) The shareholder class action lawsuit filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) alleges that Defendants made materially false and/or […]

(OtherOTC:GLUC),(OTC US:GLUC), BENTONVILLE, Ark., Oct. 21, 2025 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC) today announced the appointment of Mark Schaftlein as Chief Executive Officer and member of the Board of Directors, effective October 20, 2025. The Company also announced the appointment of Marc Hatch as Chief Financial Officer and Chief Operating Officer, effective

(NYSE:TROX),(NASDAQ:FLYE),(NASDAQ:SVRA), ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Tronox Holdings plc (TROX) The shareholder class action lawsuit filed against Tronox Holdings plc (“Tronox” or the “Company”) (NYSE: TROX) alleges that Defendants made materially

(NASDAQ:XXII), MOCKSVILLE, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, will host a webcast on Tuesday, November 4, 2025, at 8:00 AM ET to

(NASDAQ:SCOR), RESTON, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) — Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media, today announced that it plans to hold a conference call to discuss its financial results for the third quarter ended September 30, 2025, on Tuesday, November 4th at 5:00 p.m. ET. Interested parties

(NASDAQ:MLYS), ~ Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD to be presented~ ~ Phase 3 data of the Launch-HTN Trial of lorundrostat to be included in “Best of Journal of the American Medical Association and the New England Journal of

(NASDAQ:AUID), DENVER, Oct. 21, 2025 (GLOBE NEWSWIRE) — authID (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today announced that one of the largest retailers in Europe (the “Customer”), which is among the top twenty retailers globally, has selected and implemented authID's PrivacyKey biometric technology to secure

(NASDAQ:FWRG), BRADENTON, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced that it plans to release its third quarter 2025 financial results on Tuesday, November 4, 2025, before the market opens. A conference

On Thursday, November 6, Credit Cardholders Earn Automatic Extra Rewards on Purchases for 24 Hours Bank of America announced its fourth annual More Rewards Day, taking place on Thursday, November 6, 2025. As the holiday season kicks off, BofA is offering Consumer and Business credit cardholders one full day to earn bonus rewards on their

(NASDAQ:CDTX), SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak(R) platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it presented late-breaking Phase 2b clinical data on its non-vaccine influenza preventative candidate, CD388, during ID Week 2025, taking place October 19-22, 2025, in Atlanta,